首页> 外文OA文献 >Phase 3, Randomized, Double-Blind, Active-Comparator (Darbepoetin Alfa) Study of Oral Roxadustat in CKD Patients with Anemia on Hemodialysis in Japan

【2h】

Phase 3, Randomized, Double-Blind, Active-Comparator (Darbepoetin Alfa) Study of Oral Roxadustat in CKD Patients with Anemia on Hemodialysis in Japan

机译：第3阶段，随机，双盲，活性比较（Darbopoetin Alfa）在日本血液透析血液透析患者中口腔roxadustat的研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Tadao Akizawa; Manabu Iwasaki; Yusuke Yamaguchi; Yoshikatsu Majikawa; Michael Reusch;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. Phase 3, Randomized, Double-Blind, Active-Comparator (Darbepoetin Alfa) Study of Oral Roxadustat in CKD Patients with Anemia on Hemodialysis in Japan [J] . Journal of the American Society of Nephrology: JASN . 2020,第7期

机译：第3阶段，随机，双盲，活性比较器（Darbopoetin Alfa）在日本血液透析性血液透析患者中口服Roxadustat的研究
2. Roxadustat (FG-4592) Versus Epoetin Alfa for Anemia in Patients Receiving Maintenance Hemodialysis: A Phase 2, Randomized, 6-to 19-Week, Open-Label, Active-Comparator, Dose-Ranging, Safety and Exploratory Efficacy Study [J] . Provenzano Robert, Besarab Anatole, Wright Steven, American Journal of Kidney Diseases: The official journal of the National Kidney Foundation . 2016,第6期

机译：Roxadustat（FG-4592）与Epoetin Alfa对比接受维持性血液透析患者的贫血：第2阶段，随机，6到19周，开放标签，活性比较剂，剂量范围，安全性和探索性疗效研究
3. Efficacy and Safety of CKD-11101 (Proposed Biosimilar of Darbepoetin-Alfa) Compared with Darbepoetin-Alfa in Patients on Hemodialysis: A Randomized, Double-Blinded, Parallel-Group Phase III Study [J] . Kim Yaerim, Park Su-Kil, Cho Won Yong, BioDrugs: Clinical immunotherapeutics, biopharmaceuticals, and gene therapy . 2020,第1期

机译：与血液透析患者的Darbepoetin-Alfa相比，CKD-11101（Darbepoetin-Alfa的BioSimilar）的疗效和安全性：随机，双盲，平行组III研究
4. Iron and ferritin status in hemodialysis patients under darbepoetin alfa therapy [C] . Tokmak, F., Kisters, Workshop on Macro, Trace and Ultratrace Elements; 20040924-25; Jena(DE) . 2004

机译：达贝泊汀α疗法对血液透析患者铁和铁蛋白的影响
5. A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial of Fish Oil (Eicosapentaenoic Acid and Docosahexaenoic Acid) on Lung and Systemic Inflammation in Patients with Acute Lung Injury. [D] . Stapleton, Renee Doney. 2010

机译：鱼油（二十碳五烯酸和二十二碳六烯酸）对急性肺损伤患者的肺和全身炎症的II期，随机，双盲，安慰剂对照试验。
6. Phase III Randomized Study of the Effects of Parenteral Iron Oral Iron or No Iron Supplementation on the Erythropoietic Response to Darbepoetin Alfa for Patients With Chemotherapy-Associated Anemia [O] . David P. Steensma, Jeff A. Sloan, Shaker R. Dakhil, -1

机译：化疗相关性贫血患者肠胃外铁剂口服铁剂或无铁剂对达比泊汀α的红细胞生成反应影响的随机化研究的第三阶段
7. Roxadustat (FG-4592) Versus Epoetin Alfa for Anemia in Patients Receiving Maintenance Hemodialysis: A Phase 2, Randomized, 6- to 19-Week, Open-Label, Active-Comparator, Dose-Ranging, Safety and Exploratory Efficacy Study [O] . Provenzano Robert, Besarab Anatole, Wright Steven, 2016

机译：Roxadustat（FG-4592）与Epoetin Alfa对比接受维持性血液透析患者的贫血：第2阶段，随机，6到19周，开放标签，活性比较剂，剂量范围，安全性和探索性研究

Phase 3, Randomized, Double-Blind, Active-Comparator (Darbepoetin Alfa) Study of Oral Roxadustat in CKD Patients with Anemia on Hemodialysis in Japan

著录项

引文网络

相似文献

相关主题

期刊订阅